Hepatitis
<ѻý class="page-description">More in Hepatitis
Also in TTHealthWatch: HIV-positive kidney donors
Fatty acid synthase inhibitor targets main drivers of liver injury
These high reinfection rates indicate treatment has reached highest-risk population
An anesthesiologist may not have followed infection control practices
Hospital setting may offer unique opportunity to increase vaccination rates
Results as quick as 1 hour, enabling a test-and-treat approach
Androgen precursor may help cirrhosis-related sarcopenia
"Is it time to say primary prophylaxis is dead?" one expert asks
GLP-1/GIP agonist also improved fibrosis biomarkers, liver fat, and stiffness in phase II trial
Effects may be related to weight loss, not changes in fibrogenesis, expert suggests
iLFT is now an essential, highly utilized tool at one U.K. primary care system
Combo therapies for HDV with drugs other than pegylated interferon would be better, expert says
Tens of thousands contracted HIV or hepatitis from transfusions during the 1970s and 1980s
Health news and commentary gathered by ѻý staff
